131 related articles for article (PubMed ID: 30269836)
21. Titin gene mutations are common in families with both peripartum cardiomyopathy and dilated cardiomyopathy.
van Spaendonck-Zwarts KY; Posafalvi A; van den Berg MP; Hilfiker-Kleiner D; Bollen IA; Sliwa K; Alders M; Almomani R; van Langen IM; van der Meer P; Sinke RJ; van der Velden J; Van Veldhuisen DJ; van Tintelen JP; Jongbloed JD
Eur Heart J; 2014 Aug; 35(32):2165-73. PubMed ID: 24558114
[TBL] [Abstract][Full Text] [Related]
22. Prevalence of Titin Truncating Variants in General Population.
Akinrinade O; Koskenvuo JW; Alastalo TP
PLoS One; 2015; 10(12):e0145284. PubMed ID: 26701604
[TBL] [Abstract][Full Text] [Related]
23. The first titin (c.59926 + 1G > A) founder mutation associated with dilated cardiomyopathy.
Hoorntje ET; van Spaendonck-Zwarts KY; Te Rijdt WP; Boven L; Vink A; van der Smagt JJ; Asselbergs FW; van Wijngaarden J; Hennekam EA; Pinto YM; Lekanne Deprez RH; Barge-Schaapveld DQCM; Bootsma M; Regieli J; Hoedemaekers YM; Jongbloed JDH; van den Berg MP; van Tintelen JP
Eur J Heart Fail; 2018 Apr; 20(4):803-806. PubMed ID: 29057560
[No Abstract] [Full Text] [Related]
24. Functional analysis of a gene-edited mouse model to gain insights into the disease mechanisms of a titin missense variant.
Jiang H; Hooper C; Kelly M; Steeples V; Simon JN; Beglov J; Azad AJ; Leinhos L; Bennett P; Ehler E; Kalisch-Smith JI; Sparrow DB; Fischer R; Heilig R; Isackson H; Ehsan M; Patone G; Huebner N; Davies B; Watkins H; Gehmlich K
Basic Res Cardiol; 2021 Feb; 116(1):14. PubMed ID: 33637999
[TBL] [Abstract][Full Text] [Related]
25. Titin-related Cardiomyopathy: Is it a Distinct Disease?
Santiago CF; Huttner IG; Fatkin D
Curr Cardiol Rep; 2022 Sep; 24(9):1069-1075. PubMed ID: 35759169
[TBL] [Abstract][Full Text] [Related]
26. Cardiomyopathy due to PRDM16 mutation: First description of a fetal presentation, with possible modifier genes.
Delplancq G; Tarris G; Vitobello A; Nambot S; Sorlin A; Philippe C; Carmignac V; Duffourd Y; Denis C; Eicher JC; Chevarin M; Millat G; Khallouk B; Rousseau T; Falcon-Eicher S; Vasiljevic A; Harizay FT; Thauvin-Robinet C; Faivre L; Kuentz P
Am J Med Genet C Semin Med Genet; 2020 Mar; 184(1):129-135. PubMed ID: 31965688
[TBL] [Abstract][Full Text] [Related]
27. Comprehensive RNA Analysis of the NF1 Gene in Classically Affected NF1 Affected Individuals Meeting NIH Criteria has High Sensitivity and Mutation Negative Testing is Reassuring in Isolated Cases With Pigmentary Features Only.
Evans DG; Bowers N; Burkitt-Wright E; Miles E; Garg S; Scott-Kitching V; Penman-Splitt M; Dobbie A; Howard E; Ealing J; Vassalo G; Wallace AJ; Newman W; ; Huson SM
EBioMedicine; 2016 May; 7():212-20. PubMed ID: 27322474
[TBL] [Abstract][Full Text] [Related]
28. [Molecular genetic diagnosis of neurofibromatosis type I].
Polgár N; Komlósi K; Hadzsiev K; Illés T; Melegh B
Orv Hetil; 2011 Mar; 152(11):415-9. PubMed ID: 21362601
[TBL] [Abstract][Full Text] [Related]
29. Atypical hematologic and renal manifestations in neurofibromatosis type I: coincidence or pathophysiological link?
Van-Gils J; Harambat J; Jubert C; Vidaud D; Llanas B; Perel Y; Lacombe D; Goizet C
Eur J Med Genet; 2014; 57(11-12):639-42. PubMed ID: 25234363
[TBL] [Abstract][Full Text] [Related]
30. [From gene to disease; neurofibromatosis type 1].
de Goede-Bolder A; Cnossen MH; Dooijes D; van den Ouweland AM; Niermeijer MF
Ned Tijdschr Geneeskd; 2001 Sep; 145(36):1736-8. PubMed ID: 11572174
[TBL] [Abstract][Full Text] [Related]
31. A rising titan: TTN review and mutation update.
Chauveau C; Rowell J; Ferreiro A
Hum Mutat; 2014 Sep; 35(9):1046-59. PubMed ID: 24980681
[TBL] [Abstract][Full Text] [Related]
32. Truncating Titin (TTN) Variants in Chemotherapy-Induced Cardiomyopathy.
Linschoten M; Teske AJ; Baas AF; Vink A; Dooijes D; Baars HF; Asselbergs FW
J Card Fail; 2017 Jun; 23(6):476-479. PubMed ID: 28315399
[TBL] [Abstract][Full Text] [Related]
33. Partial unilateral lentiginosis is mosaic neurofibromatosis type 1 or not?
Yaşar Ş; Ersanli A; Göktay F; Aytekin S; Cebeci D; Güneş P
J Dermatol; 2017 Jan; 44(1):29-35. PubMed ID: 27439996
[TBL] [Abstract][Full Text] [Related]
34. Improved Criteria for the Classification of Titin Variants in Inherited Skeletal Myopathies.
Savarese M; Johari M; Johnson K; Arumilli M; Torella A; Töpf A; Rubegni A; Kuhn M; Giugliano T; Gläser D; Fattori F; Thompson R; Penttilä S; Lehtinen S; Gibertini S; Ruggieri A; Mora M; Maver A; Peterlin B; Mankodi A; Lochmüller H; Santorelli FM; Schoser B; Fajkusová L; Straub V; Nigro V; Hackman P; Udd B
J Neuromuscul Dis; 2020; 7(2):153-166. PubMed ID: 32039858
[TBL] [Abstract][Full Text] [Related]
35. A 'second truncation' in TTN causes early onset recessive muscular dystrophy.
Harris E; Töpf A; Vihola A; Evilä A; Barresi R; Hudson J; Hackman P; Herron B; MacArthur D; Lochmüller H; Bushby K; Udd B; Straub V
Neuromuscul Disord; 2017 Nov; 27(11):1009-1017. PubMed ID: 28716623
[TBL] [Abstract][Full Text] [Related]
36. Bilateral segmental neurofibromatosis: a case report and review.
Gonzalez G; Russi ME; Lodeiros A
Pediatr Neurol; 2007 Jan; 36(1):51-3. PubMed ID: 17162198
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic and management considerations posed by multiple café au lait spots.
Riccardi VM
Arch Dermatol; 2009 Aug; 145(8):929-30. PubMed ID: 19687427
[No Abstract] [Full Text] [Related]
38. Genotype phenotype analysis in a family carrying truncating mutations in the titin gene.
Peddareddygari LR; Baisre-de León A; Grewal RP
Acta Myol; 2021 Mar; 40(1):61-65. PubMed ID: 33870097
[TBL] [Abstract][Full Text] [Related]
39. Autosomal dominant multiple café-au-lait spots and neurofibromatosis-1: evidence of non-linkage.
Charrow J; Listernick R; Ward K
Am J Med Genet; 1993 Mar; 45(5):606-8. PubMed ID: 8456833
[TBL] [Abstract][Full Text] [Related]
40. Multiple or familial café-au-lait spots is neurofibromatosis type 6: clarification of a diagnosis.
Madson JG
Dermatol Online J; 2012 May; 18(5):4. PubMed ID: 22630574
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
